ADAGE CAPITAL PARTNERS GP, L.L.C. - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$11,550,000
-55.0%
50,000
-52.8%
0.02%
-56.9%
Q1 2023$25,679,560
-28.9%
106,000
-14.8%
0.06%
-32.6%
Q4 2022$36,104,488
+6009.1%
124,391
+1266.9%
0.09%
+8500.0%
Q3 2022$591,000
-92.2%
9,100
-88.2%
0.00%
-92.9%
Q1 2022$7,588,000
-10.5%
77,331
-22.7%
0.01%
-6.7%
Q4 2021$8,474,000
+6.2%
100,0000.0%0.02%
-6.2%
Q3 2021$7,979,000
-18.1%
100,0000.0%0.02%
-15.8%
Q2 2021$9,741,000
+33.6%
100,000
+60.5%
0.02%
+26.7%
Q1 2021$7,290,000
+100.1%
62,323
+55.8%
0.02%
+66.7%
Q4 2019$3,644,000
-9.2%
40,000
+24.8%
0.01%
-10.0%
Q1 2019$4,015,000
-3.9%
32,050
-13.5%
0.01%
-16.7%
Q4 2018$4,176,000
-39.2%
37,050
+15.6%
0.01%
-20.0%
Q3 2018$6,863,000
-50.9%
32,050
-35.9%
0.02%
-53.1%
Q2 2018$13,985,000
-52.1%
50,000
-80.0%
0.03%
-52.9%
Q1 2018$29,198,000
-29.5%
250,000
-44.6%
0.07%
-27.7%
Q4 2017$41,443,000
+84.3%
451,500
-9.7%
0.09%
+70.9%
Q3 2017$22,490,000
+130.5%
500,000
-16.7%
0.06%
+129.2%
Q2 2017$9,756,000
+58.4%
600,000
+50.0%
0.02%
+50.0%
Q1 2017$6,160,000
+18.1%
400,000
+14.3%
0.02%
+14.3%
Q4 2016$5,215,000350,0000.01%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders